Product Information
TERCONAZOLE 0.4% CREAM is a generic product labeled by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., priced at $0.5523 per GM under NDC 00168034646. Its NADAC has been published 544 times since Nov 28, 2013.
FDA first approved this application on Feb 18, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 mg/g
NDC
00168034646
Classification
Generic
Dosage Form
CREAM
Route
VAGINAL
Effective Date
9/23/2026
Active Ingredients
TERCONAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA076712FDA Approved
2/18/2005
TE Code
AB
On Market Since
2/18/2005
Pharmacological Classes
Price Statistics
The NADAC for TERCONAZOLE 0.4% CREAM has been published 544 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5523 per GM |
|---|---|
| All-time high | $0.6953 (Mar 16, 2022) |
| All-time low | $0.4786 (Nov 20, 2024) |
| 52-week high | $0.5945 |
| 52-week low | $0.5523 |
| Median price | $0.6040 |
| Average price | $0.6000 |
| Largest weekly change | +20.5% (Sep 23, 2015) |
| Weeks tracked | 544 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the terconazole market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
terconazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Azole Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TERCONAZOLE 0.4% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for TERCONAZOLE 0.4% CREAM, manufactured by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., is $0.5523 per GM (NDC 00168034646), effective Sep 30, 2026.
How has the price of TERCONAZOLE 0.4% CREAM changed over time?
Over the history we have for it, the NADAC for TERCONAZOLE 0.4% CREAM has held within roughly two percent of its current level. It has been tracked across 544 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TERCONAZOLE 0.4% CREAM?
Since Nov 28, 2013, the NADAC for TERCONAZOLE 0.4% CREAM has ranged from a low of $0.4786 (Nov 20, 2024) to a high of $0.6953 (Mar 16, 2022), with a median of $0.6040 per GM.
Are there cheaper alternatives to TERCONAZOLE 0.4% CREAM?
No other NADAC-published product currently shares the active ingredient and strength of TERCONAZOLE 0.4% CREAM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TERCONAZOLE 0.4% CREAM?
TERCONAZOLE 0.4% CREAM (NDC 00168034646) is labeled by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., and CMS classifies it as a generic product.